187 related articles for article (PubMed ID: 30927619)
1. Acid-suppressive medications and risk of pneumonia in acute stroke patients: A systematic review and meta-analysis.
Marchina S; Doros G; Modak J; Helenius J; Aycock DM; Kumar S
J Neurol Sci; 2019 May; 400():122-128. PubMed ID: 30927619
[TBL] [Abstract][Full Text] [Related]
2. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.
Eom CS; Jeon CY; Lim JW; Cho EG; Park SM; Lee KS
CMAJ; 2011 Feb; 183(3):310-9. PubMed ID: 21173070
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
[TBL] [Abstract][Full Text] [Related]
4. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
[TBL] [Abstract][Full Text] [Related]
5. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
6. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.
Herzig SJ; Doughty C; Lahoti S; Marchina S; Sanan N; Feng W; Kumar S
Ann Neurol; 2014 Nov; 76(5):712-8. PubMed ID: 25164323
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
[TBL] [Abstract][Full Text] [Related]
8. Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study.
Ho SW; Hsieh MJ; Yang SF; Yeh YT; Wang YH; Yeh CB
Medicine (Baltimore); 2015 Jul; 94(29):e1227. PubMed ID: 26200649
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: risk of fractures with acid-suppressing medication.
Kwok CS; Yeong JK; Loke YK
Bone; 2011 Apr; 48(4):768-76. PubMed ID: 21185417
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Prophylaxis of Stress Ulcer in Non-ICU Patients: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.
Liu Y; Li D; Wen A
Clin Ther; 2020 Mar; 42(3):488-498.e8. PubMed ID: 32046894
[TBL] [Abstract][Full Text] [Related]
11. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
[TBL] [Abstract][Full Text] [Related]
12. Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates.
de Vries F; Cooper AL; Cockle SM; van Staa TP; Cooper C
Osteoporos Int; 2009 Dec; 20(12):1989-98. PubMed ID: 19333676
[TBL] [Abstract][Full Text] [Related]
13. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune and immune-mediated inflammatory diseases after exposure to acid-suppressive medication: A systematic review and meta-analysis.
Nevalainen A; Nevalainen OPO
Int J Risk Saf Med; 2023; 34(3):207-225. PubMed ID: 36442213
[TBL] [Abstract][Full Text] [Related]
16. Comparing safety of proton-pump inhibitors versus H2-receptor antagonists in kidney transplant recipients: A systematic review and meta-analysis.
Mohammadi K; Yaribash S; Razi B; Dashti-Khavidaki S
J Clin Pharm Ther; 2022 May; 47(5):567-574. PubMed ID: 34931328
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
Sridharan K; Sivaramakrishnan G; Gnanaraj J
Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis.
Laoveeravat P; Thavaraputta S; Vutthikraivit W; Suchartlikitwong S; Mingbunjerdsuk T; Motes A; Nugent K; Rakvit A; Islam E; Islam S
QJM; 2020 Feb; 113(2):100-107. PubMed ID: 31503318
[TBL] [Abstract][Full Text] [Related]
19. Use of acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies.
Yang J; Zhou TJ; Yang J; Bao DN
Eur J Clin Pharmacol; 2022 Mar; 78(3):365-373. PubMed ID: 34705066
[TBL] [Abstract][Full Text] [Related]
20. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
